IBDEI04E ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10588,1,4,0)
;;=4^E10.22
;;^UTILITY(U,$J,358.3,10588,2)
;;=^5002590
;;^UTILITY(U,$J,358.3,10589,0)
;;=E10.29^^45^460^24
;;^UTILITY(U,$J,358.3,10589,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10589,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Kidney Compl
;;^UTILITY(U,$J,358.3,10589,1,4,0)
;;=4^E10.29
;;^UTILITY(U,$J,358.3,10589,2)
;;=^5002591
;;^UTILITY(U,$J,358.3,10590,0)
;;=E10.311^^45^460^12
;;^UTILITY(U,$J,358.3,10590,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10590,1,3,0)
;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,10590,1,4,0)
;;=4^E10.311
;;^UTILITY(U,$J,358.3,10590,2)
;;=^5002592
;;^UTILITY(U,$J,358.3,10591,0)
;;=E10.319^^45^460^13
;;^UTILITY(U,$J,358.3,10591,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10591,1,3,0)
;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,10591,1,4,0)
;;=4^E10.319
;;^UTILITY(U,$J,358.3,10591,2)
;;=^5002593
;;^UTILITY(U,$J,358.3,10592,0)
;;=E10.3211^^45^460^19
;;^UTILITY(U,$J,358.3,10592,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10592,1,3,0)
;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,10592,1,4,0)
;;=4^E10.3211
;;^UTILITY(U,$J,358.3,10592,2)
;;=^5138279
;;^UTILITY(U,$J,358.3,10593,0)
;;=E10.3212^^45^460^20
;;^UTILITY(U,$J,358.3,10593,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10593,1,3,0)
;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,10593,1,4,0)
;;=4^E10.3212
;;^UTILITY(U,$J,358.3,10593,2)
;;=^5138280
;;^UTILITY(U,$J,358.3,10594,0)
;;=E10.3213^^45^460^21
;;^UTILITY(U,$J,358.3,10594,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10594,1,3,0)
;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,10594,1,4,0)
;;=4^E10.3213
;;^UTILITY(U,$J,358.3,10594,2)
;;=^5138281
;;^UTILITY(U,$J,358.3,10595,0)
;;=E10.39^^45^460^26
;;^UTILITY(U,$J,358.3,10595,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10595,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,10595,1,4,0)
;;=4^E10.39
;;^UTILITY(U,$J,358.3,10595,2)
;;=^5002603
;;^UTILITY(U,$J,358.3,10596,0)
;;=E10.40^^45^460^10
;;^UTILITY(U,$J,358.3,10596,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10596,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,10596,1,4,0)
;;=4^E10.40
;;^UTILITY(U,$J,358.3,10596,2)
;;=^5002604
;;^UTILITY(U,$J,358.3,10597,0)
;;=E10.41^^45^460^7
;;^UTILITY(U,$J,358.3,10597,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10597,1,3,0)
;;=3^DM Type 1 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,10597,1,4,0)
;;=4^E10.41
;;^UTILITY(U,$J,358.3,10597,2)
;;=^5002605
;;^UTILITY(U,$J,358.3,10598,0)
;;=E10.42^^45^460^11
;;^UTILITY(U,$J,358.3,10598,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10598,1,3,0)
;;=3^DM Type 1 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,10598,1,4,0)
;;=4^E10.42
;;^UTILITY(U,$J,358.3,10598,2)
;;=^5002606
;;^UTILITY(U,$J,358.3,10599,0)
;;=E10.43^^45^460^2
;;^UTILITY(U,$J,358.3,10599,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10599,1,3,0)
;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,10599,1,4,0)
;;=4^E10.43
;;^UTILITY(U,$J,358.3,10599,2)
;;=^5002607
;;^UTILITY(U,$J,358.3,10600,0)
;;=E10.44^^45^460^1
;;^UTILITY(U,$J,358.3,10600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10600,1,3,0)
;;=3^DM Type 1 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,10600,1,4,0)
;;=4^E10.44
;;^UTILITY(U,$J,358.3,10600,2)
;;=^5002608
;;^UTILITY(U,$J,358.3,10601,0)
;;=E10.49^^45^460^25
;;^UTILITY(U,$J,358.3,10601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10601,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Neurological Compl
;;^UTILITY(U,$J,358.3,10601,1,4,0)
;;=4^E10.49
;;^UTILITY(U,$J,358.3,10601,2)
;;=^5002609
;;^UTILITY(U,$J,358.3,10602,0)
;;=E10.59^^45^460^22
;;^UTILITY(U,$J,358.3,10602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10602,1,3,0)
;;=3^DM Type 1 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,10602,1,4,0)
;;=4^E10.59
;;^UTILITY(U,$J,358.3,10602,2)
;;=^5002612
;;^UTILITY(U,$J,358.3,10603,0)
;;=E10.610^^45^460^9
;;^UTILITY(U,$J,358.3,10603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10603,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,10603,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,10603,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,10604,0)
;;=E10.618^^45^460^23
;;^UTILITY(U,$J,358.3,10604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10604,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,10604,1,4,0)
;;=4^E10.618
;;^UTILITY(U,$J,358.3,10604,2)
;;=^5002614
;;^UTILITY(U,$J,358.3,10605,0)
;;=E10.630^^45^460^30
;;^UTILITY(U,$J,358.3,10605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10605,1,3,0)
;;=3^DM Type 1 w/ Peridontal Disease
;;^UTILITY(U,$J,358.3,10605,1,4,0)
;;=4^E10.630
;;^UTILITY(U,$J,358.3,10605,2)
;;=^5002619
;;^UTILITY(U,$J,358.3,10606,0)
;;=E10.638^^45^460^27
;;^UTILITY(U,$J,358.3,10606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10606,1,3,0)
;;=3^DM Type 1 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,10606,1,4,0)
;;=4^E10.638
;;^UTILITY(U,$J,358.3,10606,2)
;;=^5002620
;;^UTILITY(U,$J,358.3,10607,0)
;;=E10.641^^45^460^15
;;^UTILITY(U,$J,358.3,10607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10607,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,10607,1,4,0)
;;=4^E10.641
;;^UTILITY(U,$J,358.3,10607,2)
;;=^5002621
;;^UTILITY(U,$J,358.3,10608,0)
;;=E10.649^^45^460^16
;;^UTILITY(U,$J,358.3,10608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10608,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,10608,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,10608,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,10609,0)
;;=E10.65^^45^460^14
;;^UTILITY(U,$J,358.3,10609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10609,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,10609,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,10609,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,10610,0)
;;=E10.69^^45^460^29
;;^UTILITY(U,$J,358.3,10610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10610,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,10610,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,10610,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,10611,0)
;;=E10.8^^45^460^33
;;^UTILITY(U,$J,358.3,10611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10611,1,3,0)
;;=3^DM Type 1 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,10611,1,4,0)
;;=4^E10.8
;;^UTILITY(U,$J,358.3,10611,2)
;;=^5002625
;;^UTILITY(U,$J,358.3,10612,0)
;;=E10.9^^45^460^34
;;^UTILITY(U,$J,358.3,10612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10612,1,3,0)
;;=3^DM Type 1 w/o Compl
;;^UTILITY(U,$J,358.3,10612,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,10612,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,10613,0)
;;=E10.620^^45^460^5
;;^UTILITY(U,$J,358.3,10613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10613,1,3,0)
;;=3^DM Type 1 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,10613,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,10613,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,10614,0)
;;=E10.36^^45^460^4
;;^UTILITY(U,$J,358.3,10614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10614,1,3,0)
;;=3^DM Type 1 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,10614,1,4,0)
;;=4^E10.36
;;^UTILITY(U,$J,358.3,10614,2)
;;=^5002602
;;^UTILITY(U,$J,358.3,10615,0)
;;=E10.621^^45^460^6
;;^UTILITY(U,$J,358.3,10615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10615,1,3,0)
;;=3^DM Type 1 w/ Diab Foot Ulcer
;;^UTILITY(U,$J,358.3,10615,1,4,0)
;;=4^E10.621
;;^UTILITY(U,$J,358.3,10615,2)
;;=^5002616
;;^UTILITY(U,$J,358.3,10616,0)
;;=E10.622^^45^460^28
;;^UTILITY(U,$J,358.3,10616,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10616,1,3,0)
;;=3^DM Type 1 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,10616,1,4,0)
;;=4^E10.622
;;^UTILITY(U,$J,358.3,10616,2)
;;=^5002617
;;^UTILITY(U,$J,358.3,10617,0)
;;=E10.51^^45^460^32
;;^UTILITY(U,$J,358.3,10617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10617,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,10617,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,10617,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,10618,0)
;;=E10.52^^45^460^31
;;^UTILITY(U,$J,358.3,10618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10618,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,10618,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,10618,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,10619,0)
;;=E11.00^^45^461^19
;;^UTILITY(U,$J,358.3,10619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10619,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
;;^UTILITY(U,$J,358.3,10619,1,4,0)
;;=4^E11.00
;;^UTILITY(U,$J,358.3,10619,2)
;;=^5002627
;;^UTILITY(U,$J,358.3,10620,0)
;;=E11.01^^45^461^18
;;^UTILITY(U,$J,358.3,10620,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10620,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
;;^UTILITY(U,$J,358.3,10620,1,4,0)
;;=4^E11.01
;;^UTILITY(U,$J,358.3,10620,2)
;;=^5002628
;;^UTILITY(U,$J,358.3,10621,0)
;;=E11.21^^45^461^7
;;^UTILITY(U,$J,358.3,10621,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10621,1,3,0)
;;=3^DM Type 2 w/ Diab Nephropathy
;;^UTILITY(U,$J,358.3,10621,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,10621,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,10622,0)
;;=E11.22^^45^461^3
;;^UTILITY(U,$J,358.3,10622,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10622,1,3,0)
;;=3^DM Type 2 w/ Diab CKD
;;^UTILITY(U,$J,358.3,10622,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,10622,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,10623,0)
;;=E11.39^^45^461^28
;;^UTILITY(U,$J,358.3,10623,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10623,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,10623,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,10623,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,10624,0)
;;=E11.41^^45^461^6
;;^UTILITY(U,$J,358.3,10624,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10624,1,3,0)
;;=3^DM Type 2 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,10624,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,10624,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,10625,0)
;;=E11.42^^45^461^13
;;^UTILITY(U,$J,358.3,10625,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10625,1,3,0)
;;=3^DM Type 2 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,10625,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,10625,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,10626,0)
;;=E11.43^^45^461^2
;;^UTILITY(U,$J,358.3,10626,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10626,1,3,0)
;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,10626,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,10626,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,10627,0)
;;=E11.44^^45^461^1
;;^UTILITY(U,$J,358.3,10627,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10627,1,3,0)
;;=3^DM Type 2 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,10627,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,10627,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,10628,0)
;;=E11.49^^45^461^8
;;^UTILITY(U,$J,358.3,10628,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10628,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,10628,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,10628,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,10629,0)
;;=E11.59^^45^461^25
;;^UTILITY(U,$J,358.3,10629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10629,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,10629,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,10629,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,10630,0)
;;=E11.610^^45^461^9
;;^UTILITY(U,$J,358.3,10630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10630,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,10630,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,10630,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,10631,0)
;;=E11.618^^45^461^26
;;^UTILITY(U,$J,358.3,10631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10631,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,10631,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,10631,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,10632,0)
;;=E11.621^^45^461^16
;;^UTILITY(U,$J,358.3,10632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10632,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,10632,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,10632,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,10633,0)
;;=E11.622^^45^461^31
;;^UTILITY(U,$J,358.3,10633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10633,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,10633,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,10633,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,10634,0)
;;=E11.628^^45^461^30
;;^UTILITY(U,$J,358.3,10634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10634,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Compl
;;^UTILITY(U,$J,358.3,10634,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,10634,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,10635,0)
;;=E11.630^^45^461^33
;;^UTILITY(U,$J,358.3,10635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10635,1,3,0)
;;=3^DM Type 2 w/ Periodontal Disease
;;^UTILITY(U,$J,358.3,10635,1,4,0)
;;=4^E11.630
;;^UTILITY(U,$J,358.3,10635,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,10636,0)
;;=E11.638^^45^461^29
;;^UTILITY(U,$J,358.3,10636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10636,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,10636,1,4,0)
;;=4^E11.638
;;^UTILITY(U,$J,358.3,10636,2)
;;=^5002660
;;^UTILITY(U,$J,358.3,10637,0)
;;=E11.641^^45^461^20
;;^UTILITY(U,$J,358.3,10637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10637,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,10637,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,10637,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,10638,0)
;;=E11.649^^45^461^21
;;^UTILITY(U,$J,358.3,10638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10638,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,10638,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,10638,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,10639,0)
;;=E11.65^^45^461^17
;;^UTILITY(U,$J,358.3,10639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10639,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,10639,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,10639,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,10640,0)
;;=E11.69^^45^461^32
;;^UTILITY(U,$J,358.3,10640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10640,1,3,0)
;;=3^DM Type 2 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,10640,1,4,0)
;;=4^E11.69
;;^UTILITY(U,$J,358.3,10640,2)
;;=^5002664
;;^UTILITY(U,$J,358.3,10641,0)
;;=E11.8^^45^461^34
;;^UTILITY(U,$J,358.3,10641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10641,1,3,0)
;;=3^DM Type 2 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,10641,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,10641,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,10642,0)
;;=E11.9^^45^461^35
;;^UTILITY(U,$J,358.3,10642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10642,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,10642,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,10642,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,10643,0)
;;=E11.29^^45^461^27
;;^UTILITY(U,$J,358.3,10643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10643,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Kidney Compl
;;^UTILITY(U,$J,358.3,10643,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,10643,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,10644,0)
;;=E11.311^^45^461^14
;;^UTILITY(U,$J,358.3,10644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10644,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
;;^UTILITY(U,$J,358.3,10644,1,4,0)
;;=4^E11.311
;;^UTILITY(U,$J,358.3,10644,2)
;;=E11.319^5002632
;;^UTILITY(U,$J,358.3,10645,0)
;;=E11.319^^45^461^15
;;^UTILITY(U,$J,358.3,10645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10645,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
;;^UTILITY(U,$J,358.3,10645,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,10645,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,10646,0)
;;=E11.3211^^45^461^22
;;^UTILITY(U,$J,358.3,10646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10646,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,10646,1,4,0)
;;=4^E11.3211
;;^UTILITY(U,$J,358.3,10646,2)
;;=^5138331
;;^UTILITY(U,$J,358.3,10647,0)
;;=E11.3212^^45^461^23
;;^UTILITY(U,$J,358.3,10647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10647,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,10647,1,4,0)
;;=4^E11.3212
;;^UTILITY(U,$J,358.3,10647,2)
;;=^5138332
;;^UTILITY(U,$J,358.3,10648,0)
;;=E11.3213^^45^461^24
;;^UTILITY(U,$J,358.3,10648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10648,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,10648,1,4,0)
;;=4^E11.3213
;;^UTILITY(U,$J,358.3,10648,2)
;;=^5138333
;;^UTILITY(U,$J,358.3,10649,0)
;;=E11.40^^45^461^10
;;^UTILITY(U,$J,358.3,10649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10649,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,10649,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,10649,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,10650,0)
;;=E11.51^^45^461^12
;;^UTILITY(U,$J,358.3,10650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10650,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,10650,1,4,0)
;;=4^E11.51
;;^UTILITY(U,$J,358.3,10650,2)
;;=^5002650
;;^UTILITY(U,$J,358.3,10651,0)
;;=E11.52^^45^461^11
;;^UTILITY(U,$J,358.3,10651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10651,1,3,0)
;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,10651,1,4,0)
;;=4^E11.52
;;^UTILITY(U,$J,358.3,10651,2)
;;=^5002651
;;^UTILITY(U,$J,358.3,10652,0)
;;=E11.620^^45^461^5
;;^UTILITY(U,$J,358.3,10652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10652,1,3,0)
;;=3^DM Type 2 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,10652,1,4,0)
;;=4^E11.620
;;^UTILITY(U,$J,358.3,10652,2)
;;=^5002655
;;^UTILITY(U,$J,358.3,10653,0)
;;=E11.36^^45^461^4
;;^UTILITY(U,$J,358.3,10653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10653,1,3,0)
;;=3^DM Type 2 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,10653,1,4,0)
;;=4^E11.36
;;^UTILITY(U,$J,358.3,10653,2)
;;=^5002642
;;^UTILITY(U,$J,358.3,10654,0)
;;=I10.^^45^462^1
;;^UTILITY(U,$J,358.3,10654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10654,1,3,0)
;;=3^Essential/Primary Hypertension
;;^UTILITY(U,$J,358.3,10654,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,10654,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,10655,0)
;;=I11.0^^45^462^12
;;^UTILITY(U,$J,358.3,10655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10655,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
;;^UTILITY(U,$J,358.3,10655,1,4,0)
;;=4^I11.0
;;^UTILITY(U,$J,358.3,10655,2)
;;=^5007063
;;^UTILITY(U,$J,358.3,10656,0)
;;=I11.9^^45^462^13
;;^UTILITY(U,$J,358.3,10656,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI04E 19778 printed Sep 23, 2025@19:17:23 Page 2
IBDEI04E ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10588,1,4,0)
+2 ;;=4^E10.22
+3 ;;^UTILITY(U,$J,358.3,10588,2)
+4 ;;=^5002590
+5 ;;^UTILITY(U,$J,358.3,10589,0)
+6 ;;=E10.29^^45^460^24
+7 ;;^UTILITY(U,$J,358.3,10589,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,10589,1,3,0)
+10 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
+11 ;;^UTILITY(U,$J,358.3,10589,1,4,0)
+12 ;;=4^E10.29
+13 ;;^UTILITY(U,$J,358.3,10589,2)
+14 ;;=^5002591
+15 ;;^UTILITY(U,$J,358.3,10590,0)
+16 ;;=E10.311^^45^460^12
+17 ;;^UTILITY(U,$J,358.3,10590,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,10590,1,3,0)
+20 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
+21 ;;^UTILITY(U,$J,358.3,10590,1,4,0)
+22 ;;=4^E10.311
+23 ;;^UTILITY(U,$J,358.3,10590,2)
+24 ;;=^5002592
+25 ;;^UTILITY(U,$J,358.3,10591,0)
+26 ;;=E10.319^^45^460^13
+27 ;;^UTILITY(U,$J,358.3,10591,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,10591,1,3,0)
+30 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
+31 ;;^UTILITY(U,$J,358.3,10591,1,4,0)
+32 ;;=4^E10.319
+33 ;;^UTILITY(U,$J,358.3,10591,2)
+34 ;;=^5002593
+35 ;;^UTILITY(U,$J,358.3,10592,0)
+36 ;;=E10.3211^^45^460^19
+37 ;;^UTILITY(U,$J,358.3,10592,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,10592,1,3,0)
+40 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
+41 ;;^UTILITY(U,$J,358.3,10592,1,4,0)
+42 ;;=4^E10.3211
+43 ;;^UTILITY(U,$J,358.3,10592,2)
+44 ;;=^5138279
+45 ;;^UTILITY(U,$J,358.3,10593,0)
+46 ;;=E10.3212^^45^460^20
+47 ;;^UTILITY(U,$J,358.3,10593,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,10593,1,3,0)
+50 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+51 ;;^UTILITY(U,$J,358.3,10593,1,4,0)
+52 ;;=4^E10.3212
+53 ;;^UTILITY(U,$J,358.3,10593,2)
+54 ;;=^5138280
+55 ;;^UTILITY(U,$J,358.3,10594,0)
+56 ;;=E10.3213^^45^460^21
+57 ;;^UTILITY(U,$J,358.3,10594,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,10594,1,3,0)
+60 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+61 ;;^UTILITY(U,$J,358.3,10594,1,4,0)
+62 ;;=4^E10.3213
+63 ;;^UTILITY(U,$J,358.3,10594,2)
+64 ;;=^5138281
+65 ;;^UTILITY(U,$J,358.3,10595,0)
+66 ;;=E10.39^^45^460^26
+67 ;;^UTILITY(U,$J,358.3,10595,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,10595,1,3,0)
+70 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
+71 ;;^UTILITY(U,$J,358.3,10595,1,4,0)
+72 ;;=4^E10.39
+73 ;;^UTILITY(U,$J,358.3,10595,2)
+74 ;;=^5002603
+75 ;;^UTILITY(U,$J,358.3,10596,0)
+76 ;;=E10.40^^45^460^10
+77 ;;^UTILITY(U,$J,358.3,10596,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,10596,1,3,0)
+80 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
+81 ;;^UTILITY(U,$J,358.3,10596,1,4,0)
+82 ;;=4^E10.40
+83 ;;^UTILITY(U,$J,358.3,10596,2)
+84 ;;=^5002604
+85 ;;^UTILITY(U,$J,358.3,10597,0)
+86 ;;=E10.41^^45^460^7
+87 ;;^UTILITY(U,$J,358.3,10597,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,10597,1,3,0)
+90 ;;=3^DM Type 1 w/ Diab Mononeuropathy
+91 ;;^UTILITY(U,$J,358.3,10597,1,4,0)
+92 ;;=4^E10.41
+93 ;;^UTILITY(U,$J,358.3,10597,2)
+94 ;;=^5002605
+95 ;;^UTILITY(U,$J,358.3,10598,0)
+96 ;;=E10.42^^45^460^11
+97 ;;^UTILITY(U,$J,358.3,10598,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,10598,1,3,0)
+100 ;;=3^DM Type 1 w/ Diab Polyneuropathy
+101 ;;^UTILITY(U,$J,358.3,10598,1,4,0)
+102 ;;=4^E10.42
+103 ;;^UTILITY(U,$J,358.3,10598,2)
+104 ;;=^5002606
+105 ;;^UTILITY(U,$J,358.3,10599,0)
+106 ;;=E10.43^^45^460^2
+107 ;;^UTILITY(U,$J,358.3,10599,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,10599,1,3,0)
+110 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
+111 ;;^UTILITY(U,$J,358.3,10599,1,4,0)
+112 ;;=4^E10.43
+113 ;;^UTILITY(U,$J,358.3,10599,2)
+114 ;;=^5002607
+115 ;;^UTILITY(U,$J,358.3,10600,0)
+116 ;;=E10.44^^45^460^1
+117 ;;^UTILITY(U,$J,358.3,10600,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,10600,1,3,0)
+120 ;;=3^DM Type 1 w/ Diab Amyotrophy
+121 ;;^UTILITY(U,$J,358.3,10600,1,4,0)
+122 ;;=4^E10.44
+123 ;;^UTILITY(U,$J,358.3,10600,2)
+124 ;;=^5002608
+125 ;;^UTILITY(U,$J,358.3,10601,0)
+126 ;;=E10.49^^45^460^25
+127 ;;^UTILITY(U,$J,358.3,10601,1,0)
+128 ;;=^358.31IA^4^2
+129 ;;^UTILITY(U,$J,358.3,10601,1,3,0)
+130 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
+131 ;;^UTILITY(U,$J,358.3,10601,1,4,0)
+132 ;;=4^E10.49
+133 ;;^UTILITY(U,$J,358.3,10601,2)
+134 ;;=^5002609
+135 ;;^UTILITY(U,$J,358.3,10602,0)
+136 ;;=E10.59^^45^460^22
+137 ;;^UTILITY(U,$J,358.3,10602,1,0)
+138 ;;=^358.31IA^4^2
+139 ;;^UTILITY(U,$J,358.3,10602,1,3,0)
+140 ;;=3^DM Type 1 w/ Oth Circulatory Compl
+141 ;;^UTILITY(U,$J,358.3,10602,1,4,0)
+142 ;;=4^E10.59
+143 ;;^UTILITY(U,$J,358.3,10602,2)
+144 ;;=^5002612
+145 ;;^UTILITY(U,$J,358.3,10603,0)
+146 ;;=E10.610^^45^460^9
+147 ;;^UTILITY(U,$J,358.3,10603,1,0)
+148 ;;=^358.31IA^4^2
+149 ;;^UTILITY(U,$J,358.3,10603,1,3,0)
+150 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
+151 ;;^UTILITY(U,$J,358.3,10603,1,4,0)
+152 ;;=4^E10.610
+153 ;;^UTILITY(U,$J,358.3,10603,2)
+154 ;;=^5002613
+155 ;;^UTILITY(U,$J,358.3,10604,0)
+156 ;;=E10.618^^45^460^23
+157 ;;^UTILITY(U,$J,358.3,10604,1,0)
+158 ;;=^358.31IA^4^2
+159 ;;^UTILITY(U,$J,358.3,10604,1,3,0)
+160 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
+161 ;;^UTILITY(U,$J,358.3,10604,1,4,0)
+162 ;;=4^E10.618
+163 ;;^UTILITY(U,$J,358.3,10604,2)
+164 ;;=^5002614
+165 ;;^UTILITY(U,$J,358.3,10605,0)
+166 ;;=E10.630^^45^460^30
+167 ;;^UTILITY(U,$J,358.3,10605,1,0)
+168 ;;=^358.31IA^4^2
+169 ;;^UTILITY(U,$J,358.3,10605,1,3,0)
+170 ;;=3^DM Type 1 w/ Peridontal Disease
+171 ;;^UTILITY(U,$J,358.3,10605,1,4,0)
+172 ;;=4^E10.630
+173 ;;^UTILITY(U,$J,358.3,10605,2)
+174 ;;=^5002619
+175 ;;^UTILITY(U,$J,358.3,10606,0)
+176 ;;=E10.638^^45^460^27
+177 ;;^UTILITY(U,$J,358.3,10606,1,0)
+178 ;;=^358.31IA^4^2
+179 ;;^UTILITY(U,$J,358.3,10606,1,3,0)
+180 ;;=3^DM Type 1 w/ Oth Oral Compl
+181 ;;^UTILITY(U,$J,358.3,10606,1,4,0)
+182 ;;=4^E10.638
+183 ;;^UTILITY(U,$J,358.3,10606,2)
+184 ;;=^5002620
+185 ;;^UTILITY(U,$J,358.3,10607,0)
+186 ;;=E10.641^^45^460^15
+187 ;;^UTILITY(U,$J,358.3,10607,1,0)
+188 ;;=^358.31IA^4^2
+189 ;;^UTILITY(U,$J,358.3,10607,1,3,0)
+190 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
+191 ;;^UTILITY(U,$J,358.3,10607,1,4,0)
+192 ;;=4^E10.641
+193 ;;^UTILITY(U,$J,358.3,10607,2)
+194 ;;=^5002621
+195 ;;^UTILITY(U,$J,358.3,10608,0)
+196 ;;=E10.649^^45^460^16
+197 ;;^UTILITY(U,$J,358.3,10608,1,0)
+198 ;;=^358.31IA^4^2
+199 ;;^UTILITY(U,$J,358.3,10608,1,3,0)
+200 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
+201 ;;^UTILITY(U,$J,358.3,10608,1,4,0)
+202 ;;=4^E10.649
+203 ;;^UTILITY(U,$J,358.3,10608,2)
+204 ;;=^5002622
+205 ;;^UTILITY(U,$J,358.3,10609,0)
+206 ;;=E10.65^^45^460^14
+207 ;;^UTILITY(U,$J,358.3,10609,1,0)
+208 ;;=^358.31IA^4^2
+209 ;;^UTILITY(U,$J,358.3,10609,1,3,0)
+210 ;;=3^DM Type 1 w/ Hyperglycemia
+211 ;;^UTILITY(U,$J,358.3,10609,1,4,0)
+212 ;;=4^E10.65
+213 ;;^UTILITY(U,$J,358.3,10609,2)
+214 ;;=^5002623
+215 ;;^UTILITY(U,$J,358.3,10610,0)
+216 ;;=E10.69^^45^460^29
+217 ;;^UTILITY(U,$J,358.3,10610,1,0)
+218 ;;=^358.31IA^4^2
+219 ;;^UTILITY(U,$J,358.3,10610,1,3,0)
+220 ;;=3^DM Type 1 w/ Oth Spec Compl
+221 ;;^UTILITY(U,$J,358.3,10610,1,4,0)
+222 ;;=4^E10.69
+223 ;;^UTILITY(U,$J,358.3,10610,2)
+224 ;;=^5002624
+225 ;;^UTILITY(U,$J,358.3,10611,0)
+226 ;;=E10.8^^45^460^33
+227 ;;^UTILITY(U,$J,358.3,10611,1,0)
+228 ;;=^358.31IA^4^2
+229 ;;^UTILITY(U,$J,358.3,10611,1,3,0)
+230 ;;=3^DM Type 1 w/ Unspec Compl
+231 ;;^UTILITY(U,$J,358.3,10611,1,4,0)
+232 ;;=4^E10.8
+233 ;;^UTILITY(U,$J,358.3,10611,2)
+234 ;;=^5002625
+235 ;;^UTILITY(U,$J,358.3,10612,0)
+236 ;;=E10.9^^45^460^34
+237 ;;^UTILITY(U,$J,358.3,10612,1,0)
+238 ;;=^358.31IA^4^2
+239 ;;^UTILITY(U,$J,358.3,10612,1,3,0)
+240 ;;=3^DM Type 1 w/o Compl
+241 ;;^UTILITY(U,$J,358.3,10612,1,4,0)
+242 ;;=4^E10.9
+243 ;;^UTILITY(U,$J,358.3,10612,2)
+244 ;;=^5002626
+245 ;;^UTILITY(U,$J,358.3,10613,0)
+246 ;;=E10.620^^45^460^5
+247 ;;^UTILITY(U,$J,358.3,10613,1,0)
+248 ;;=^358.31IA^4^2
+249 ;;^UTILITY(U,$J,358.3,10613,1,3,0)
+250 ;;=3^DM Type 1 w/ Diab Dermatitis
+251 ;;^UTILITY(U,$J,358.3,10613,1,4,0)
+252 ;;=4^E10.620
+253 ;;^UTILITY(U,$J,358.3,10613,2)
+254 ;;=^5002615
+255 ;;^UTILITY(U,$J,358.3,10614,0)
+256 ;;=E10.36^^45^460^4
+257 ;;^UTILITY(U,$J,358.3,10614,1,0)
+258 ;;=^358.31IA^4^2
+259 ;;^UTILITY(U,$J,358.3,10614,1,3,0)
+260 ;;=3^DM Type 1 w/ Diab Cataract
+261 ;;^UTILITY(U,$J,358.3,10614,1,4,0)
+262 ;;=4^E10.36
+263 ;;^UTILITY(U,$J,358.3,10614,2)
+264 ;;=^5002602
+265 ;;^UTILITY(U,$J,358.3,10615,0)
+266 ;;=E10.621^^45^460^6
+267 ;;^UTILITY(U,$J,358.3,10615,1,0)
+268 ;;=^358.31IA^4^2
+269 ;;^UTILITY(U,$J,358.3,10615,1,3,0)
+270 ;;=3^DM Type 1 w/ Diab Foot Ulcer
+271 ;;^UTILITY(U,$J,358.3,10615,1,4,0)
+272 ;;=4^E10.621
+273 ;;^UTILITY(U,$J,358.3,10615,2)
+274 ;;=^5002616
+275 ;;^UTILITY(U,$J,358.3,10616,0)
+276 ;;=E10.622^^45^460^28
+277 ;;^UTILITY(U,$J,358.3,10616,1,0)
+278 ;;=^358.31IA^4^2
+279 ;;^UTILITY(U,$J,358.3,10616,1,3,0)
+280 ;;=3^DM Type 1 w/ Oth Skin Ulcer
+281 ;;^UTILITY(U,$J,358.3,10616,1,4,0)
+282 ;;=4^E10.622
+283 ;;^UTILITY(U,$J,358.3,10616,2)
+284 ;;=^5002617
+285 ;;^UTILITY(U,$J,358.3,10617,0)
+286 ;;=E10.51^^45^460^32
+287 ;;^UTILITY(U,$J,358.3,10617,1,0)
+288 ;;=^358.31IA^4^2
+289 ;;^UTILITY(U,$J,358.3,10617,1,3,0)
+290 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
+291 ;;^UTILITY(U,$J,358.3,10617,1,4,0)
+292 ;;=4^E10.51
+293 ;;^UTILITY(U,$J,358.3,10617,2)
+294 ;;=^5002610
+295 ;;^UTILITY(U,$J,358.3,10618,0)
+296 ;;=E10.52^^45^460^31
+297 ;;^UTILITY(U,$J,358.3,10618,1,0)
+298 ;;=^358.31IA^4^2
+299 ;;^UTILITY(U,$J,358.3,10618,1,3,0)
+300 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
+301 ;;^UTILITY(U,$J,358.3,10618,1,4,0)
+302 ;;=4^E10.52
+303 ;;^UTILITY(U,$J,358.3,10618,2)
+304 ;;=^5002611
+305 ;;^UTILITY(U,$J,358.3,10619,0)
+306 ;;=E11.00^^45^461^19
+307 ;;^UTILITY(U,$J,358.3,10619,1,0)
+308 ;;=^358.31IA^4^2
+309 ;;^UTILITY(U,$J,358.3,10619,1,3,0)
+310 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
+311 ;;^UTILITY(U,$J,358.3,10619,1,4,0)
+312 ;;=4^E11.00
+313 ;;^UTILITY(U,$J,358.3,10619,2)
+314 ;;=^5002627
+315 ;;^UTILITY(U,$J,358.3,10620,0)
+316 ;;=E11.01^^45^461^18
+317 ;;^UTILITY(U,$J,358.3,10620,1,0)
+318 ;;=^358.31IA^4^2
+319 ;;^UTILITY(U,$J,358.3,10620,1,3,0)
+320 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
+321 ;;^UTILITY(U,$J,358.3,10620,1,4,0)
+322 ;;=4^E11.01
+323 ;;^UTILITY(U,$J,358.3,10620,2)
+324 ;;=^5002628
+325 ;;^UTILITY(U,$J,358.3,10621,0)
+326 ;;=E11.21^^45^461^7
+327 ;;^UTILITY(U,$J,358.3,10621,1,0)
+328 ;;=^358.31IA^4^2
+329 ;;^UTILITY(U,$J,358.3,10621,1,3,0)
+330 ;;=3^DM Type 2 w/ Diab Nephropathy
+331 ;;^UTILITY(U,$J,358.3,10621,1,4,0)
+332 ;;=4^E11.21
+333 ;;^UTILITY(U,$J,358.3,10621,2)
+334 ;;=^5002629
+335 ;;^UTILITY(U,$J,358.3,10622,0)
+336 ;;=E11.22^^45^461^3
+337 ;;^UTILITY(U,$J,358.3,10622,1,0)
+338 ;;=^358.31IA^4^2
+339 ;;^UTILITY(U,$J,358.3,10622,1,3,0)
+340 ;;=3^DM Type 2 w/ Diab CKD
+341 ;;^UTILITY(U,$J,358.3,10622,1,4,0)
+342 ;;=4^E11.22
+343 ;;^UTILITY(U,$J,358.3,10622,2)
+344 ;;=^5002630
+345 ;;^UTILITY(U,$J,358.3,10623,0)
+346 ;;=E11.39^^45^461^28
+347 ;;^UTILITY(U,$J,358.3,10623,1,0)
+348 ;;=^358.31IA^4^2
+349 ;;^UTILITY(U,$J,358.3,10623,1,3,0)
+350 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
+351 ;;^UTILITY(U,$J,358.3,10623,1,4,0)
+352 ;;=4^E11.39
+353 ;;^UTILITY(U,$J,358.3,10623,2)
+354 ;;=^5002643
+355 ;;^UTILITY(U,$J,358.3,10624,0)
+356 ;;=E11.41^^45^461^6
+357 ;;^UTILITY(U,$J,358.3,10624,1,0)
+358 ;;=^358.31IA^4^2
+359 ;;^UTILITY(U,$J,358.3,10624,1,3,0)
+360 ;;=3^DM Type 2 w/ Diab Mononeuropathy
+361 ;;^UTILITY(U,$J,358.3,10624,1,4,0)
+362 ;;=4^E11.41
+363 ;;^UTILITY(U,$J,358.3,10624,2)
+364 ;;=^5002645
+365 ;;^UTILITY(U,$J,358.3,10625,0)
+366 ;;=E11.42^^45^461^13
+367 ;;^UTILITY(U,$J,358.3,10625,1,0)
+368 ;;=^358.31IA^4^2
+369 ;;^UTILITY(U,$J,358.3,10625,1,3,0)
+370 ;;=3^DM Type 2 w/ Diab Polyneuropathy
+371 ;;^UTILITY(U,$J,358.3,10625,1,4,0)
+372 ;;=4^E11.42
+373 ;;^UTILITY(U,$J,358.3,10625,2)
+374 ;;=^5002646
+375 ;;^UTILITY(U,$J,358.3,10626,0)
+376 ;;=E11.43^^45^461^2
+377 ;;^UTILITY(U,$J,358.3,10626,1,0)
+378 ;;=^358.31IA^4^2
+379 ;;^UTILITY(U,$J,358.3,10626,1,3,0)
+380 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
+381 ;;^UTILITY(U,$J,358.3,10626,1,4,0)
+382 ;;=4^E11.43
+383 ;;^UTILITY(U,$J,358.3,10626,2)
+384 ;;=^5002647
+385 ;;^UTILITY(U,$J,358.3,10627,0)
+386 ;;=E11.44^^45^461^1
+387 ;;^UTILITY(U,$J,358.3,10627,1,0)
+388 ;;=^358.31IA^4^2
+389 ;;^UTILITY(U,$J,358.3,10627,1,3,0)
+390 ;;=3^DM Type 2 w/ Diab Amyotrophy
+391 ;;^UTILITY(U,$J,358.3,10627,1,4,0)
+392 ;;=4^E11.44
+393 ;;^UTILITY(U,$J,358.3,10627,2)
+394 ;;=^5002648
+395 ;;^UTILITY(U,$J,358.3,10628,0)
+396 ;;=E11.49^^45^461^8
+397 ;;^UTILITY(U,$J,358.3,10628,1,0)
+398 ;;=^358.31IA^4^2
+399 ;;^UTILITY(U,$J,358.3,10628,1,3,0)
+400 ;;=3^DM Type 2 w/ Diab Neurological Compl
+401 ;;^UTILITY(U,$J,358.3,10628,1,4,0)
+402 ;;=4^E11.49
+403 ;;^UTILITY(U,$J,358.3,10628,2)
+404 ;;=^5002649
+405 ;;^UTILITY(U,$J,358.3,10629,0)
+406 ;;=E11.59^^45^461^25
+407 ;;^UTILITY(U,$J,358.3,10629,1,0)
+408 ;;=^358.31IA^4^2
+409 ;;^UTILITY(U,$J,358.3,10629,1,3,0)
+410 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+411 ;;^UTILITY(U,$J,358.3,10629,1,4,0)
+412 ;;=4^E11.59
+413 ;;^UTILITY(U,$J,358.3,10629,2)
+414 ;;=^5002652
+415 ;;^UTILITY(U,$J,358.3,10630,0)
+416 ;;=E11.610^^45^461^9
+417 ;;^UTILITY(U,$J,358.3,10630,1,0)
+418 ;;=^358.31IA^4^2
+419 ;;^UTILITY(U,$J,358.3,10630,1,3,0)
+420 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+421 ;;^UTILITY(U,$J,358.3,10630,1,4,0)
+422 ;;=4^E11.610
+423 ;;^UTILITY(U,$J,358.3,10630,2)
+424 ;;=^5002653
+425 ;;^UTILITY(U,$J,358.3,10631,0)
+426 ;;=E11.618^^45^461^26
+427 ;;^UTILITY(U,$J,358.3,10631,1,0)
+428 ;;=^358.31IA^4^2
+429 ;;^UTILITY(U,$J,358.3,10631,1,3,0)
+430 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+431 ;;^UTILITY(U,$J,358.3,10631,1,4,0)
+432 ;;=4^E11.618
+433 ;;^UTILITY(U,$J,358.3,10631,2)
+434 ;;=^5002654
+435 ;;^UTILITY(U,$J,358.3,10632,0)
+436 ;;=E11.621^^45^461^16
+437 ;;^UTILITY(U,$J,358.3,10632,1,0)
+438 ;;=^358.31IA^4^2
+439 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
+440 ;;=3^DM Type 2 w/ Foot Ulcer
+441 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
+442 ;;=4^E11.621
+443 ;;^UTILITY(U,$J,358.3,10632,2)
+444 ;;=^5002656
+445 ;;^UTILITY(U,$J,358.3,10633,0)
+446 ;;=E11.622^^45^461^31
+447 ;;^UTILITY(U,$J,358.3,10633,1,0)
+448 ;;=^358.31IA^4^2
+449 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
+450 ;;=3^DM Type 2 w/ Oth Skin Ulcer
+451 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
+452 ;;=4^E11.622
+453 ;;^UTILITY(U,$J,358.3,10633,2)
+454 ;;=^5002657
+455 ;;^UTILITY(U,$J,358.3,10634,0)
+456 ;;=E11.628^^45^461^30
+457 ;;^UTILITY(U,$J,358.3,10634,1,0)
+458 ;;=^358.31IA^4^2
+459 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
+460 ;;=3^DM Type 2 w/ Oth Skin Compl
+461 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
+462 ;;=4^E11.628
+463 ;;^UTILITY(U,$J,358.3,10634,2)
+464 ;;=^5002658
+465 ;;^UTILITY(U,$J,358.3,10635,0)
+466 ;;=E11.630^^45^461^33
+467 ;;^UTILITY(U,$J,358.3,10635,1,0)
+468 ;;=^358.31IA^4^2
+469 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
+470 ;;=3^DM Type 2 w/ Periodontal Disease
+471 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
+472 ;;=4^E11.630
+473 ;;^UTILITY(U,$J,358.3,10635,2)
+474 ;;=^5002659
+475 ;;^UTILITY(U,$J,358.3,10636,0)
+476 ;;=E11.638^^45^461^29
+477 ;;^UTILITY(U,$J,358.3,10636,1,0)
+478 ;;=^358.31IA^4^2
+479 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
+480 ;;=3^DM Type 2 w/ Oth Oral Compl
+481 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
+482 ;;=4^E11.638
+483 ;;^UTILITY(U,$J,358.3,10636,2)
+484 ;;=^5002660
+485 ;;^UTILITY(U,$J,358.3,10637,0)
+486 ;;=E11.641^^45^461^20
+487 ;;^UTILITY(U,$J,358.3,10637,1,0)
+488 ;;=^358.31IA^4^2
+489 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
+490 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+491 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
+492 ;;=4^E11.641
+493 ;;^UTILITY(U,$J,358.3,10637,2)
+494 ;;=^5002661
+495 ;;^UTILITY(U,$J,358.3,10638,0)
+496 ;;=E11.649^^45^461^21
+497 ;;^UTILITY(U,$J,358.3,10638,1,0)
+498 ;;=^358.31IA^4^2
+499 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
+500 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+501 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
+502 ;;=4^E11.649
+503 ;;^UTILITY(U,$J,358.3,10638,2)
+504 ;;=^5002662
+505 ;;^UTILITY(U,$J,358.3,10639,0)
+506 ;;=E11.65^^45^461^17
+507 ;;^UTILITY(U,$J,358.3,10639,1,0)
+508 ;;=^358.31IA^4^2
+509 ;;^UTILITY(U,$J,358.3,10639,1,3,0)
+510 ;;=3^DM Type 2 w/ Hyperglycemia
+511 ;;^UTILITY(U,$J,358.3,10639,1,4,0)
+512 ;;=4^E11.65
+513 ;;^UTILITY(U,$J,358.3,10639,2)
+514 ;;=^5002663
+515 ;;^UTILITY(U,$J,358.3,10640,0)
+516 ;;=E11.69^^45^461^32
+517 ;;^UTILITY(U,$J,358.3,10640,1,0)
+518 ;;=^358.31IA^4^2
+519 ;;^UTILITY(U,$J,358.3,10640,1,3,0)
+520 ;;=3^DM Type 2 w/ Oth Spec Compl
+521 ;;^UTILITY(U,$J,358.3,10640,1,4,0)
+522 ;;=4^E11.69
+523 ;;^UTILITY(U,$J,358.3,10640,2)
+524 ;;=^5002664
+525 ;;^UTILITY(U,$J,358.3,10641,0)
+526 ;;=E11.8^^45^461^34
+527 ;;^UTILITY(U,$J,358.3,10641,1,0)
+528 ;;=^358.31IA^4^2
+529 ;;^UTILITY(U,$J,358.3,10641,1,3,0)
+530 ;;=3^DM Type 2 w/ Unspec Compl
+531 ;;^UTILITY(U,$J,358.3,10641,1,4,0)
+532 ;;=4^E11.8
+533 ;;^UTILITY(U,$J,358.3,10641,2)
+534 ;;=^5002665
+535 ;;^UTILITY(U,$J,358.3,10642,0)
+536 ;;=E11.9^^45^461^35
+537 ;;^UTILITY(U,$J,358.3,10642,1,0)
+538 ;;=^358.31IA^4^2
+539 ;;^UTILITY(U,$J,358.3,10642,1,3,0)
+540 ;;=3^DM Type 2 w/o Complications
+541 ;;^UTILITY(U,$J,358.3,10642,1,4,0)
+542 ;;=4^E11.9
+543 ;;^UTILITY(U,$J,358.3,10642,2)
+544 ;;=^5002666
+545 ;;^UTILITY(U,$J,358.3,10643,0)
+546 ;;=E11.29^^45^461^27
+547 ;;^UTILITY(U,$J,358.3,10643,1,0)
+548 ;;=^358.31IA^4^2
+549 ;;^UTILITY(U,$J,358.3,10643,1,3,0)
+550 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
+551 ;;^UTILITY(U,$J,358.3,10643,1,4,0)
+552 ;;=4^E11.29
+553 ;;^UTILITY(U,$J,358.3,10643,2)
+554 ;;=^5002631
+555 ;;^UTILITY(U,$J,358.3,10644,0)
+556 ;;=E11.311^^45^461^14
+557 ;;^UTILITY(U,$J,358.3,10644,1,0)
+558 ;;=^358.31IA^4^2
+559 ;;^UTILITY(U,$J,358.3,10644,1,3,0)
+560 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
+561 ;;^UTILITY(U,$J,358.3,10644,1,4,0)
+562 ;;=4^E11.311
+563 ;;^UTILITY(U,$J,358.3,10644,2)
+564 ;;=E11.319^5002632
+565 ;;^UTILITY(U,$J,358.3,10645,0)
+566 ;;=E11.319^^45^461^15
+567 ;;^UTILITY(U,$J,358.3,10645,1,0)
+568 ;;=^358.31IA^4^2
+569 ;;^UTILITY(U,$J,358.3,10645,1,3,0)
+570 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
+571 ;;^UTILITY(U,$J,358.3,10645,1,4,0)
+572 ;;=4^E11.319
+573 ;;^UTILITY(U,$J,358.3,10645,2)
+574 ;;=^5002633
+575 ;;^UTILITY(U,$J,358.3,10646,0)
+576 ;;=E11.3211^^45^461^22
+577 ;;^UTILITY(U,$J,358.3,10646,1,0)
+578 ;;=^358.31IA^4^2
+579 ;;^UTILITY(U,$J,358.3,10646,1,3,0)
+580 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
+581 ;;^UTILITY(U,$J,358.3,10646,1,4,0)
+582 ;;=4^E11.3211
+583 ;;^UTILITY(U,$J,358.3,10646,2)
+584 ;;=^5138331
+585 ;;^UTILITY(U,$J,358.3,10647,0)
+586 ;;=E11.3212^^45^461^23
+587 ;;^UTILITY(U,$J,358.3,10647,1,0)
+588 ;;=^358.31IA^4^2
+589 ;;^UTILITY(U,$J,358.3,10647,1,3,0)
+590 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+591 ;;^UTILITY(U,$J,358.3,10647,1,4,0)
+592 ;;=4^E11.3212
+593 ;;^UTILITY(U,$J,358.3,10647,2)
+594 ;;=^5138332
+595 ;;^UTILITY(U,$J,358.3,10648,0)
+596 ;;=E11.3213^^45^461^24
+597 ;;^UTILITY(U,$J,358.3,10648,1,0)
+598 ;;=^358.31IA^4^2
+599 ;;^UTILITY(U,$J,358.3,10648,1,3,0)
+600 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+601 ;;^UTILITY(U,$J,358.3,10648,1,4,0)
+602 ;;=4^E11.3213
+603 ;;^UTILITY(U,$J,358.3,10648,2)
+604 ;;=^5138333
+605 ;;^UTILITY(U,$J,358.3,10649,0)
+606 ;;=E11.40^^45^461^10
+607 ;;^UTILITY(U,$J,358.3,10649,1,0)
+608 ;;=^358.31IA^4^2
+609 ;;^UTILITY(U,$J,358.3,10649,1,3,0)
+610 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
+611 ;;^UTILITY(U,$J,358.3,10649,1,4,0)
+612 ;;=4^E11.40
+613 ;;^UTILITY(U,$J,358.3,10649,2)
+614 ;;=^5002644
+615 ;;^UTILITY(U,$J,358.3,10650,0)
+616 ;;=E11.51^^45^461^12
+617 ;;^UTILITY(U,$J,358.3,10650,1,0)
+618 ;;=^358.31IA^4^2
+619 ;;^UTILITY(U,$J,358.3,10650,1,3,0)
+620 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
+621 ;;^UTILITY(U,$J,358.3,10650,1,4,0)
+622 ;;=4^E11.51
+623 ;;^UTILITY(U,$J,358.3,10650,2)
+624 ;;=^5002650
+625 ;;^UTILITY(U,$J,358.3,10651,0)
+626 ;;=E11.52^^45^461^11
+627 ;;^UTILITY(U,$J,358.3,10651,1,0)
+628 ;;=^358.31IA^4^2
+629 ;;^UTILITY(U,$J,358.3,10651,1,3,0)
+630 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
+631 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
+632 ;;=4^E11.52
+633 ;;^UTILITY(U,$J,358.3,10651,2)
+634 ;;=^5002651
+635 ;;^UTILITY(U,$J,358.3,10652,0)
+636 ;;=E11.620^^45^461^5
+637 ;;^UTILITY(U,$J,358.3,10652,1,0)
+638 ;;=^358.31IA^4^2
+639 ;;^UTILITY(U,$J,358.3,10652,1,3,0)
+640 ;;=3^DM Type 2 w/ Diab Dermatitis
+641 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
+642 ;;=4^E11.620
+643 ;;^UTILITY(U,$J,358.3,10652,2)
+644 ;;=^5002655
+645 ;;^UTILITY(U,$J,358.3,10653,0)
+646 ;;=E11.36^^45^461^4
+647 ;;^UTILITY(U,$J,358.3,10653,1,0)
+648 ;;=^358.31IA^4^2
+649 ;;^UTILITY(U,$J,358.3,10653,1,3,0)
+650 ;;=3^DM Type 2 w/ Diab Cataract
+651 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
+652 ;;=4^E11.36
+653 ;;^UTILITY(U,$J,358.3,10653,2)
+654 ;;=^5002642
+655 ;;^UTILITY(U,$J,358.3,10654,0)
+656 ;;=I10.^^45^462^1
+657 ;;^UTILITY(U,$J,358.3,10654,1,0)
+658 ;;=^358.31IA^4^2
+659 ;;^UTILITY(U,$J,358.3,10654,1,3,0)
+660 ;;=3^Essential/Primary Hypertension
+661 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
+662 ;;=4^I10.
+663 ;;^UTILITY(U,$J,358.3,10654,2)
+664 ;;=^5007062
+665 ;;^UTILITY(U,$J,358.3,10655,0)
+666 ;;=I11.0^^45^462^12
+667 ;;^UTILITY(U,$J,358.3,10655,1,0)
+668 ;;=^358.31IA^4^2
+669 ;;^UTILITY(U,$J,358.3,10655,1,3,0)
+670 ;;=3^Hypertensive Heart Disease w/ Heart Failure
+671 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
+672 ;;=4^I11.0
+673 ;;^UTILITY(U,$J,358.3,10655,2)
+674 ;;=^5007063
+675 ;;^UTILITY(U,$J,358.3,10656,0)
+676 ;;=I11.9^^45^462^13
+677 ;;^UTILITY(U,$J,358.3,10656,1,0)
+678 ;;=^358.31IA^4^2
